BRD6989

CAS No. 642008-81-9

BRD6989 ( BRD-6989;BRD 6989 )

Catalog No. M15440 CAS No. 642008-81-9

A novel potent, selective CDK8 inhibitor with IC50 of 0.5 uM against recombinant Cyclin C/CDK8 complex; displays no activity against several CDKs involved in cell cycle including CDK19 (IC50>30 uM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 60 Get Quote
10MG 88 Get Quote
25MG 186 Get Quote
50MG 332 Get Quote
100MG 494 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    BRD6989
  • Note
    Research use only, not for human use.
  • Brief Description
    A novel potent, selective CDK8 inhibitor with IC50 of 0.5 uM against recombinant Cyclin C/CDK8 complex; displays no activity against several CDKs involved in cell cycle including CDK19 (IC50>30 uM).
  • Description
    A novel potent, selective CDK8 inhibitor with IC50 of 0.5 uM against recombinant Cyclin C/CDK8 complex; displays no activity against several CDKs involved in cell cycle including CDK19 (IC50>30 uM); inhibits IFNγ-induced phosphorylation of STAT1 at Ser 727 site in BMDCs, selectively upregulates IL-10 with EC50 of 1 uM.
  • Synonyms
    BRD-6989;BRD 6989
  • Pathway
    Angiogenesis
  • Target
    CDK
  • Recptor
    CDK
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    642008-81-9
  • Formula Weight
    264.33
  • Molecular Formula
    C16H16N4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC1CCC2=C(C1)C(=C(C(=N2)N)C#N)C3=CN=CC=C3
  • Chemical Name
    2-amino-6-methyl-4-(pyridin-3-yl)-5,6,7,8-tetrahydroquinoline-3-carbonitrile

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Johannessen L, et al. Nat Chem Biol. 2017 Oct;13(10):1102-1108.
molnova catalog
related products
  • YKL-1-116

    YKL-1-116 is a potent, selective and covalent inhibitor of CDK7 that does not inhibit other CDKs; synergizes with 5-FU or nutlin-3 to kill HCT116 cells.

  • Lerociclib dihydroch...

    Lerociclib dihydrochloride is a potent and selective inhibitor of CDK4/CDK6, with IC50s of 2 nM and 1 nM for CDK6/CyclinD3?and CDK4/CyclinD1, respectively.?

  • Roniciclib

    A novel potent, orally active, pan-CDK inhibitor with IC50 of 7/9/11 nM for CDK1/2/4 respectively, inhibits transcriptional CDK9/7 with IC50 of 5-25 nM.